128 related articles for article (PubMed ID: 33882369)
1. LncRNA CRNDE promotes the progression and angiogenesis of pancreatic cancer via miR-451a/CDKN2D axis.
Zhu HY; Gao YJ; Wang Y; Liang C; Zhang ZX; Chen Y
Transl Oncol; 2021 Jul; 14(7):101088. PubMed ID: 33882369
[TBL] [Abstract][Full Text] [Related]
2. Long Non-Coding RNA CRNDE Regulates Angiogenesis in Hepatoblastoma by Targeting the MiR-203/VEGFA Axis.
Chen LJ; Yuan MX; Ji CY; Zhang YB; Peng YM; Zhang T; Gao HQ; Sheng XY; Liu ZY; Xie WX; Yin Q
Pathobiology; 2020; 87(3):161-170. PubMed ID: 32182608
[TBL] [Abstract][Full Text] [Related]
3. Corrigendum to " LncRNA CRNDE promotes the progression and angiogenesis of pancreatic cancer via miR-451a/CDKN2D axis" [Translational Oncology 14(7):101088].
Zhu HY; Gao YJ; Wang Y; Liang C; Zhang ZX; Chen Y
Transl Oncol; 2021 Oct; 14(10):101143. PubMed ID: 34303156
[No Abstract] [Full Text] [Related]
4. LncRNA CRNDE promotes cell proliferation, invasion and migration by competitively binding miR-384 in papillary thyroid cancer.
Sun H; He L; Ma L; Lu T; Wei J; Xie K; Wang X
Oncotarget; 2017 Dec; 8(66):110552-110565. PubMed ID: 29299168
[TBL] [Abstract][Full Text] [Related]
5. LncRNA CRNDE acts as an oncogene in cervical cancer through sponging miR-183 to regulate CCNB1 expression.
Bai X; Wang W; Zhao P; Wen J; Guo X; Shen T; Shen J; Yang X
Carcinogenesis; 2020 Mar; 41(1):111-121. PubMed ID: 31605132
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA CRNDE promotes the proliferation, migration and invasion of hepatocellular carcinoma cells through miR-217/MAPK1 axis.
Wang H; Ke J; Guo Q; Barnabo Nampoukime KP; Yang P; Ma K
J Cell Mol Med; 2018 Dec; 22(12):5862-5876. PubMed ID: 30246921
[TBL] [Abstract][Full Text] [Related]
7. lncRNA CRNDE promotes the proliferation and metastasis by acting as sponge miR-539-5p to regulate POU2F1 expression in HCC.
Li Z; Wu G; Li J; Wang Y; Ju X; Jiang W
BMC Cancer; 2020 Apr; 20(1):282. PubMed ID: 32252678
[TBL] [Abstract][Full Text] [Related]
8. LncRNA CRNDE promotes hepatocellular carcinoma progression by upregulating SIX1 through modulating miR-337-3p.
Tang D; Zhao L; Peng C; Ran K; Mu R; Ao Y
J Cell Biochem; 2019 Sep; 120(9):16128-16142. PubMed ID: 31099050
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA CRNDE promotes proliferation, migration and invasion in prostate cancer through miR-101/Rap1A.
Chen JH; Tong W; Pu XF; Wang JZ
Neoplasma; 2020 May; 67(3):584-594. PubMed ID: 32182086
[TBL] [Abstract][Full Text] [Related]
10. CRNDE Contributes Cervical Cancer Progression by Regulating miR-4262/ZEB1 Axis.
Ren L; Yang S; Cao Q; Tian J
Onco Targets Ther; 2021; 14():355-366. PubMed ID: 33469312
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of LncRNA CRNDE aggravates kidney injury via increasing MiR-181a-5p in sepsis.
Wang J; Song J; Li Y; Shao J; Xie Z; Sun K
Int Immunopharmacol; 2020 Feb; 79():105933. PubMed ID: 31877497
[TBL] [Abstract][Full Text] [Related]
12. The Long Non-Coding RNA CRNDE Promotes Colorectal Carcinoma Progression by Competitively Binding miR-217 with TCF7L2 and Enhancing the Wnt/β-Catenin Signaling Pathway.
Yu B; Ye X; Du Q; Zhu B; Zhai Q; Li XX
Cell Physiol Biochem; 2017; 41(6):2489-2502. PubMed ID: 28472810
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA CRNDE promotes non-small cell lung cancer progression via sponging microRNA-338-3p.
Jing H; Xia H; Qian M; Lv X
Biomed Pharmacother; 2019 Feb; 110():825-833. PubMed ID: 30554121
[TBL] [Abstract][Full Text] [Related]
14. Long Noncoding RNA CRNDE Promotes Proliferation of Gastric Cancer Cells by Targeting miR-145.
Hu CE; Du PZ; Zhang HD; Huang GJ
Cell Physiol Biochem; 2017; 42(1):13-21. PubMed ID: 28490034
[TBL] [Abstract][Full Text] [Related]
15. lncRNA CRNDE is Upregulated in Glioblastoma Multiforme and Facilitates Cancer Progression Through Targeting miR-337-3p and ELMOD2 Axis.
Gao J; Chen Q; Zhao Y; Hou R
Onco Targets Ther; 2020; 13():9225-9234. PubMed ID: 32982309
[TBL] [Abstract][Full Text] [Related]
16. LncRNA CRNDE regulates trophoblast cell proliferation, invasion, and migration via modulating miR-1277.
Zhu H; Kong L
Am J Transl Res; 2019; 11(9):5905-5918. PubMed ID: 31632559
[TBL] [Abstract][Full Text] [Related]
17. Long Non-Coding RNA CRNDE Promotes Colorectal Carcinoma Cell Progression and Paclitaxel Resistance by Regulating miR-126-5p/ATAD2 Axis.
Liu C; Hou J; Shan F; Wang L; Lu H; Ren T
Onco Targets Ther; 2020; 13():4931-4942. PubMed ID: 32581554
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA CRNDE exacerbates NPC advancement mediated by the miR-545-5p/CCND2 axis.
Ge S; Jiang C; Li M; Cheng Z; Feng X
Cancer Cell Int; 2021 Dec; 21(1):650. PubMed ID: 34863152
[TBL] [Abstract][Full Text] [Related]
19. LncRNA CRNDE promotes hepatic carcinoma cell proliferation, migration and invasion by suppressing miR-384.
Chen Z; Yu C; Zhan L; Pan Y; Chen L; Sun C
Am J Cancer Res; 2016; 6(10):2299-2309. PubMed ID: 27822419
[TBL] [Abstract][Full Text] [Related]
20. The lncRNA CRNDE promotes colorectal cancer cell proliferation and chemoresistance via miR-181a-5p-mediated regulation of Wnt/β-catenin signaling.
Han P; Li JW; Zhang BM; Lv JC; Li YM; Gu XY; Yu ZW; Jia YH; Bai XF; Li L; Liu YL; Cui BB
Mol Cancer; 2017 Jan; 16(1):9. PubMed ID: 28086904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
